Development of a Pharmaceutical Apotransferrin Product for Iron Binding Therapy
- 31 March 2001
- journal article
- Published by Elsevier in Biologicals
- Vol. 29 (1) , 27-37
- https://doi.org/10.1006/biol.2001.0273
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Exogenous Apotransferrin and Exchange Transfusions in Hereditary Iron Overload DiseasePediatrics, 2000
- Non‐transferrin‐bound iron and cellular toxicityJournal of Gastroenterology and Hepatology, 1999
- Presence and Significance of Parvovirus B19 in Blood and Blood ProductsBiologicals, 1998
- Clinical studies with solvent detergent-treated productsTransfusion Medicine Reviews, 1996
- Improved Resolution and Very High Sensitivity in MALDI TOF of Matrix Surfaces Made by Fast EvaporationAnalytical Chemistry, 1994
- Nanofiltration, a New Specific Virus Elimination Method Applied to High‐Purity Factor IX and Factor XI ConcentratesVox Sanguinis, 1994
- Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy.Journal of Clinical Pathology, 1994
- Large‐Scale Production and Properties of a Solvent‐Detergent‐Treated Factor IX Concentrate from Human PlasmaVox Sanguinis, 1988
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- A rapid method for the production control of the non-ionic component in synthetic detergentsThe Analyst, 1969